Cohanzick Management’s Zura Bio ZURA Stock Holding History

Cohanzick Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50,000	Closed	-$496K	–	399
2022 Q1	$496K	Buy	+50,000	New	+$493K	0.11%	164

Other funds holding ZURA

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Cohanzick Management's ZURA Position: Q2 2022 in Review

Cohanzick Management sold out of Zura Bio (ZURA) in Q2 2022, closing a stake of 50,000 shares — an estimated $496K sold.

Cohanzick Management first reported a position in ZURA in Q1 2022 and held it in 1 quarter. The position peaked at $496K in Q1 2022. 36 funds tracked by Wall St. Rank hold ZURA as of Q2 2022.

Cohanzick Management reported no remaining Zura Bio position as of Q2 2022 after selling out during the quarter.
Cohanzick Management sold 50,000 Zura Bio shares in Q2 2022, an estimated $496K.
Cohanzick Management first reported a position in Zura Bio in Q1 2022 and held it in 1 quarter.
Cohanzick Management's Zura Bio position peaked at $496K in Q1 2022.
36 funds tracked by Wall St. Rank held Zura Bio as of Q2 2022.

Based on Cohanzick Management's 13F filing for Q2 2022, filed 12 Aug 2022.